SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-062448
Filing Date
2012-11-14
Accepted
2012-11-14 15:45:24
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 v326313_10q.htm 10-Q 318103
2 EX-31.1 v326313_ex31-1.htm EX-31.1 10584
3 EX-31.2 v326313_ex31-2.htm EX-31.2 10528
4 EX-32.1 v326313_ex32-1.htm EX-32.1 4274
5 EX-32.2 v326313_ex32-2.htm EX-32.2 4445
  Complete submission text file 0001144204-12-062448.txt   2703956

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20120930.xml EX-101.INS 285976
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20120930.xsd EX-101.SCH 32019
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20120930_cal.xml EX-101.CAL 23190
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20120930_def.xml EX-101.DEF 146674
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20120930_lab.xml EX-101.LAB 275327
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20120930_pre.xml EX-101.PRE 180688
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 121204139
SIC: 2834 Pharmaceutical Preparations